Drug profile

The FDA adverse-event record for Allergy Tablet (Unknown)

165 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Allergy Tablet (Unknown). See the species affected, top reactions, and outcomes below.

165
adverse-event reports
1.2%
death-coded share
Dog
most-reported species
56
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
165
Total Reports
2
Deaths Reported
1.2%
Death Rate

Active Ingredients

Allergy Tablet (Unknown)

Administration Routes

OralUnknownTopical

Species Affected

Dog 154
Human 6
Cat 4
Unknown 1

Most Affected Breeds

Retriever - Labrador 17
Shih Tzu 8
Chihuahua 7
Unknown 7
Spaniel - Cocker American 7
Beagle 6
Dog (unknown) 6
Maltese 6
Terrier (unspecified) 6
Crossbred Canine/dog 6

Most Reported Reactions

Emesis 56
Vomiting 23
Lack of efficacy (ectoparasite) - flea 22
Lethargy (see also Central nervous system depression in 'Neurological') 19
Lack of efficacy - NOS 12
Diarrhoea 10
Pruritus 8
Itching 7
Emesis (multiple) 6
Not eating 6
Behavioural disorder NOS 6
Accidental exposure 5

Outcome Breakdown

Recovered/Normal
90 (54.9%)
Outcome Unknown
43 (26.2%)
Recovered with Sequela
15 (9.1%)
Ongoing
14 (8.5%)
Died
1 (0.6%)
Euthanized
1 (0.6%)

Allergy Tablet (Unknown) Adverse Event Insights

165 reports name Allergy Tablet (Unknown); 2 recorded a death outcome (1.2% of reported events, not a population-level mortality rate). Active ingredient: Allergy Tablet (Unknown). Administration routes: Oral, Unknown, Topical.

By species: Dog (154 reports), Human (6 reports), Cat (4 reports). By breed: Retriever - Labrador (17), Shih Tzu (8), Chihuahua (7).

Leading clinical signs: Emesis (56), Vomiting (23), Lack of efficacy (ectoparasite) - flea (22), Lethargy (see also Central nervous system depression in 'Neurological') (19). Outcome, 164 coded reports: Recovered/Normal leads at 54.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.